IL149139A0 - Pharmaceutical compositions containing metformin and glyburide - Google Patents
Pharmaceutical compositions containing metformin and glyburideInfo
- Publication number
- IL149139A0 IL149139A0 IL14913900A IL14913900A IL149139A0 IL 149139 A0 IL149139 A0 IL 149139A0 IL 14913900 A IL14913900 A IL 14913900A IL 14913900 A IL14913900 A IL 14913900A IL 149139 A0 IL149139 A0 IL 149139A0
- Authority
- IL
- Israel
- Prior art keywords
- glyburide
- pharmaceutical compositions
- compositions containing
- containing metformin
- metformin
- Prior art date
Links
- 229960004580 glibenclamide Drugs 0.000 title 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 title 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title 1
- 229960003105 metformin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/432,465 US6586438B2 (en) | 1999-11-03 | 1999-11-03 | Antidiabetic formulation and method |
| US09/460,920 US7598262B2 (en) | 1999-11-03 | 1999-12-14 | Method for treating diabetes |
| PCT/US2000/028311 WO2001032157A2 (en) | 1999-11-03 | 2000-10-13 | Pharmaceutical composition comprising a combination of metformin and glibenclamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL149139A0 true IL149139A0 (en) | 2002-11-10 |
Family
ID=27029501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14913900A IL149139A0 (en) | 1999-11-03 | 2000-10-13 | Pharmaceutical compositions containing metformin and glyburide |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1229918B1 (https=) |
| JP (1) | JP5183844B2 (https=) |
| KR (1) | KR20070089259A (https=) |
| CN (1) | CN1450902A (https=) |
| AR (1) | AR026356A1 (https=) |
| AT (1) | ATE390140T1 (https=) |
| AU (1) | AU780106B2 (https=) |
| BR (1) | BR0015294A (https=) |
| CA (1) | CA2389928C (https=) |
| EE (1) | EE05260B1 (https=) |
| HU (1) | HU229352B1 (https=) |
| IL (1) | IL149139A0 (https=) |
| LT (1) | LT5058B (https=) |
| LV (1) | LV12910B (https=) |
| MX (1) | MXPA02004282A (https=) |
| NO (1) | NO330026B1 (https=) |
| NZ (1) | NZ518278A (https=) |
| PL (1) | PL199278B1 (https=) |
| RU (1) | RU2275915C2 (https=) |
| SK (1) | SK287810B6 (https=) |
| TW (1) | TWI280125B (https=) |
| UY (1) | UY26424A1 (https=) |
| WO (1) | WO2001032157A2 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7563774B2 (en) | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| FR2816840B1 (fr) | 2000-11-17 | 2004-04-09 | Flamel Tech Sa | Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation |
| FR2825023B1 (fr) * | 2001-05-23 | 2005-04-15 | Flamel Tech Sa | Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif |
| WO2003011273A1 (en) * | 2001-07-31 | 2003-02-13 | The Governement Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Metformin in the treatment of hyperglycemic conditions |
| EP1492511B3 (fr) | 2002-04-09 | 2012-05-02 | Flamel Technologies | Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s) |
| US8911781B2 (en) | 2002-06-17 | 2014-12-16 | Inventia Healthcare Private Limited | Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides |
| EP1680115A1 (en) * | 2003-10-30 | 2006-07-19 | Tioga Pharmaceuticals, Inc. | Use of selective opiate receptor modulators in the treatment of neuropathy |
| SG149814A1 (en) * | 2003-12-19 | 2009-02-27 | Omega Bio Pharma Ip3 Ltd | Compositions and methods for treating diabetes |
| MXPA06012752A (es) * | 2004-05-03 | 2007-02-14 | Omega Bio Pharma Ip3 Ltd | Cisteaminas para tratar complicaciones de hipercolesterolemia y diabetes. |
| EA020870B1 (ru) | 2007-07-19 | 2015-02-27 | Такеда Фармасьютикал Компани Лимитед | Твердый препарат, включающий алоглиптин и гидрохлорид метформина |
| RS56990B1 (sr) | 2007-09-10 | 2018-05-31 | Janssen Pharmaceutica Nv | Postupak za dobijanje jedinjenja koja su korisna kao inhibitori sglt |
| RU2372911C1 (ru) * | 2008-03-12 | 2009-11-20 | Николай Евгеньевич Староверов | Полиморфная аналоговая терапия |
| US9056850B2 (en) | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
| RS59913B1 (sr) | 2008-10-17 | 2020-03-31 | Sanofi Aventis Deutschland | Kombinacija insulina i glp-1-agonista |
| US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
| PT3345593T (pt) | 2009-11-13 | 2023-11-27 | Sanofi Aventis Deutschland | Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina |
| MY180661A (en) | 2009-11-13 | 2020-12-04 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine |
| SG10201506114UA (en) | 2010-05-11 | 2015-09-29 | Janssen Pharmaceutica Nv | Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt |
| PL2611458T3 (pl) | 2010-08-30 | 2017-02-28 | Sanofi-Aventis Deutschland Gmbh | Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2 |
| AU2012213435B2 (en) * | 2011-02-02 | 2017-03-30 | Sanofi-Aventis Deutschland Gmbh | Prevention of hypoglycaemia in diabetes mellitus type 2 patients |
| US20120277147A1 (en) * | 2011-03-29 | 2012-11-01 | Sanofi-Aventis Deutschland Gmbh | Prevention of hypoglycaemia in diabetes mellitus type 2 patients |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| EP3229828B1 (en) | 2014-12-12 | 2023-04-05 | Sanofi-Aventis Deutschland GmbH | Insulin glargine/lixisenatide fixed ratio formulation |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| US20170071970A1 (en) | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
| CN110804017A (zh) * | 2019-10-31 | 2020-02-18 | 天津大学 | 磺酰脲化合物与二甲双胍成盐、制备方法和应用 |
| CN113143940A (zh) * | 2020-12-30 | 2021-07-23 | 成都恒瑞制药有限公司 | 一种抗糖尿病药物组合物的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3174901A (en) | 1963-01-31 | 1965-03-23 | Jan Marcel Didier Aron Samuel | Process for the oral treatment of diabetes |
| DE3833439A1 (de) * | 1988-10-01 | 1991-09-12 | Hoechst Ag | Verfahren zur mikronisierung von glibenclamid |
| DK36392D0 (da) | 1992-03-19 | 1992-03-19 | Novo Nordisk As | Anvendelse af kemisk forbindelse |
| TWI238064B (en) | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| IT1276130B1 (it) * | 1995-11-14 | 1997-10-27 | Gentili Ist Spa | Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo |
| KR20060105005A (ko) | 1997-06-18 | 2006-10-09 | 스미스클라인비이참피이엘시이 | 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료 |
| AU738804B2 (en) * | 1997-12-08 | 2001-09-27 | Bristol-Myers Squibb Company | Novel salts of metformin and method |
| ES2206868T3 (es) * | 1998-07-15 | 2004-05-16 | Merck Sante | Comprimidos que comprenden una combinacion de metformin glibenclamida. |
| EP2620443A1 (en) | 2012-01-25 | 2013-07-31 | Galecto Biotech AB | Novel galactoside inhibitors of galectins |
-
2000
- 2000-10-13 BR BR0015294-3A patent/BR0015294A/pt not_active Application Discontinuation
- 2000-10-13 AU AU10826/01A patent/AU780106B2/en not_active Expired
- 2000-10-13 KR KR1020077018914A patent/KR20070089259A/ko not_active Withdrawn
- 2000-10-13 EP EP00972122A patent/EP1229918B1/en not_active Expired - Lifetime
- 2000-10-13 IL IL14913900A patent/IL149139A0/xx unknown
- 2000-10-13 JP JP2001534362A patent/JP5183844B2/ja not_active Expired - Fee Related
- 2000-10-13 MX MXPA02004282A patent/MXPA02004282A/es active IP Right Grant
- 2000-10-13 WO PCT/US2000/028311 patent/WO2001032157A2/en not_active Ceased
- 2000-10-13 CA CA2389928A patent/CA2389928C/en not_active Expired - Lifetime
- 2000-10-13 HU HU0300218A patent/HU229352B1/hu unknown
- 2000-10-13 EE EEP200200242A patent/EE05260B1/xx unknown
- 2000-10-13 SK SK500-2002A patent/SK287810B6/sk not_active IP Right Cessation
- 2000-10-13 PL PL364885A patent/PL199278B1/pl unknown
- 2000-10-13 RU RU2002114820/14A patent/RU2275915C2/ru active
- 2000-10-13 CN CN00818032A patent/CN1450902A/zh active Pending
- 2000-10-13 AT AT00972122T patent/ATE390140T1/de not_active IP Right Cessation
- 2000-10-13 NZ NZ518278A patent/NZ518278A/en not_active IP Right Cessation
- 2000-10-27 TW TW089122713A patent/TWI280125B/zh not_active IP Right Cessation
- 2000-11-02 UY UY26424A patent/UY26424A1/es not_active Application Discontinuation
- 2000-11-03 AR ARP000105805A patent/AR026356A1/es unknown
-
2002
- 2002-05-02 NO NO20022087A patent/NO330026B1/no not_active IP Right Cessation
- 2002-05-24 LT LT2002063A patent/LT5058B/lt not_active IP Right Cessation
- 2002-06-03 LV LVP-02-94A patent/LV12910B/lv unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL149139A0 (en) | Pharmaceutical compositions containing metformin and glyburide | |
| IL149138A0 (en) | Pharmaceutical compositions containing metformin | |
| HUP0203939A3 (en) | Pharmaceutical compounds and compositions containing them and their use | |
| HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| IL150383A0 (en) | Glyburide and pharmaceutical compositions containing the same | |
| HUP0200714A3 (en) | Pharmaceutical compounds, pharmaceutical compositions containing them and their use | |
| PT1213020E (pt) | Compostos e composições farmacêuticas com actividade supressora do apetite | |
| HUP0203700A3 (en) | N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents and pharmaceutical compositions containing them | |
| IL155196A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
| IL133097A0 (en) | Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
| HUP0105204A3 (en) | Substituted phenethylamine derivatives and pharmaceutical compositions containing them | |
| HUP0200747A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| IL137505A (en) | Pharmaceutical compositions containing tramadol | |
| HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
| HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
| HUP0201910A3 (en) | Novel aminobenzophenones, pharmaceutical compositions containing them and their use | |
| HUP0003189A2 (en) | Pharmaceutical composition comprising fexofenadine and its derivatives | |
| HUP0101733A3 (en) | Pharmaceutical compositions containing sulfonyl-dipeptides and their use | |
| HUP0001940A3 (en) | Benzisothiazole derivatives, their use and pharmaceutical compositions containing them | |
| IL133928A0 (en) | Pharmaceutical composition containing peptichemio |